LBTLBT InnovationsLBT info
$0.01info-5.56%24h
Global rank
Market cap$0
Change 7d-5.56%
YTD Performance70.00%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Category
Business data

    LBT Innovations (LBT) Stock Overview

    LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

    LBT Stock Information

    Symbol
    LBT
    Address
    16 Anster StreetAdelaide, SA 5000Australia
    Founded
    -
    Trading hours
    -
    Website
    https://www.lbtinnovations.com
    Country
    🇦🇺 Australia
    Phone Number
    61 8 8227 1555

    LBT Innovations (LBT) Price Chart

    -
    Value:-

    LBT Innovations Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.010822855323889862
    N/A
    Market Cap
    $0
    N/A
    Employees
    19.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org